|1.||Murck, Harald: 5 articles (09/2010 - 11/2002)|
|2.||Ploch, Michael: 2 articles (09/2010 - 03/2006)|
|3.||Mannel, Marcus: 2 articles (09/2010 - 07/2004)|
|4.||Kuhn, Ulrike: 1 article (09/2010)|
|5.||Schmidt, Ulrich: 1 article (09/2010)|
|6.||Schaffler, Klaus: 1 article (03/2006)|
|7.||Seibel, Klaus: 1 article (03/2006)|
|8.||Spitznagel, Heidi: 1 article (03/2006)|
|9.||Fava, Maurizio: 1 article (10/2005)|
|10.||Alpert, Jonathan: 1 article (10/2005)|
|1.||Somatoform Disorders (Somatoform Disorder)
07/01/2004 - "Administration of 600 mg of SJW extract LI 160 daily is effective and safe in the treatment of somatoform disorders, thereby confirming results from a previous study."
11/01/2002 - "This was a multicentre, randomised, placebo controlled, 6-week trial comparing the efficacy of LI 160 (600 mg/day) and placebo in 151 out-patients suffering from somatization disorder (ICD-10: F45.0), undifferentiated somatoform disorder (F45.1), or somatoform autonomic dysfunctions (F45.3). "
11/01/2002 - "Therefore, the efficacy of the Hypericum extract LI 160 in patients with somatoform disorders should be studied in a double-blind placebo-controlled fashion. "
07/01/2004 - "In a prospective, randomized, placebo-controlled, and double-blind parallel group study, 184 outpatients with somatization disorder (ICD-10 F45.0), undifferentiated somatoform disorder (F45.1), and somatoform autonomic dysfunction (F45.3), but not major depression, received either 300 mg of SJW extract LI 160 twice daily or matching placebo for 6 weeks. "
11/01/2002 - "The data from this trial show excellent efficacy and tolerability for LI 160 in somatoform disorders. "
|2.||Depressive Disorder (Melancholia)
09/09/1999 - "[Clinical efficacy and tolerance of the hypericum special extract LI 160 in depressive disorders--a drug monitoring study]."
07/01/2001 - "Taken together, our findings suggest that Hypericum LI 160 can affect rapidly-acting as well as slower-developing, long-term biochemical mechanisms related to depressive disorders."
07/01/2001 - "In addition, Hypericum LI 160 inhibits norepinephrine uptake in SK-N-SH cells, a human neuroblastoma cell line enriched in norepinephrine transporters. "
10/01/1994 - "The influence of hypericum extract LI 160 on the expression of serotonin receptors was investigated using a neuroblastoma cell line to establish a model for the regulation of neurotransmitters by immunologically active compounds such as cytokines. "
|4.||Schizophrenia (Dementia Praecox)
|5.||Disorders of Excessive Somnolence (Hypersomnia)
|1.||Neurotransmitter Agents (Neurotransmitter)